<a href="https://laohu8.com/S/NVO">Novo Nordisk</a> A/S Announces Insider Sale of Shares by Executive Vice President Martin Holst Lange
Novo Nordisk A/S has announced trading activities involving its shares by board members, executives, and associated persons. Martin Holst Lange, an Executive Vice President, sold 13,950 shares of Novo Nordisk B, identification code DK0062498333, on August 7, 2025. The transactions were conducted outside a trading venue and at Citigroup Global Markets Europe AG - EMEA Trading. The company disclosed this information in compliance with market abuse regulations.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Novo Nordisk A/S published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW1001121892-en) on August 07, 2025, and is solely responsible for the information contained therein.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。